OverviewSuggest Edit

Amplia Therapeutics is a pharmaceutical company developing Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. It focuses on pancreatic and ovarian cancer as well as idiopathic pulmonary fibrosis (IPF).
TypePublic
Founded2016
HQMelbourne, AU
Websiteampliatx.com

Locations

Amplia Therapeutics is headquartered in
Melbourne, Australia

Location Map

Latest Updates

Share Price (Oct 2020)$0.2 (-5%)
Cybersecurity ratingAMore

Amplia Therapeutics Office Locations

Amplia Therapeutics has an office in Melbourne
Melbourne, AU (HQ)
29/55 Collins St
Show all (1)

Amplia Therapeutics Financials and Metrics

Amplia Therapeutics Revenue

Market capitalization (2-Oct-2020)

17.2m

Closing stock price (2-Oct-2020)

0.2
Amplia Therapeutics's current market capitalization is $17.2 m.
Show all financial metrics

Amplia Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Amplia Therapeutics Online and Social Media Presence

Embed Graph

Amplia Therapeutics Frequently Asked Questions

  • When was Amplia Therapeutics founded?

    Amplia Therapeutics was founded in 2016.

  • Who are Amplia Therapeutics competitors?

    Competitors of Amplia Therapeutics include Merrimack Pharmaceuticals, Infinity Pharmaceuticals and Northwest Biotherapeutics.

  • Where is Amplia Therapeutics headquarters?

    Amplia Therapeutics headquarters is located at 29/55 Collins St, Melbourne.

  • Where are Amplia Therapeutics offices?

    Amplia Therapeutics has an office in Melbourne.

  • How many offices does Amplia Therapeutics have?

    Amplia Therapeutics has 1 office.